According to a study published online October 9 in the Journal of the National Cancer Institute a low-fat diet might decrease the risk of ovarian cancer in postmenopausal women.
Previous reports from the Women's Health Initiative Dietary Modification Randomized Controlled Trial examined the effect of a low-fat diet on the risk of breast and colorectal cancer in postmenopausal women, but it was not yet known whether the same diet would alter ovarian cancer risk.
Ovarian Cancer Patients' Survival Time Increased With Experimental Drug
An experimental drug called pertuzumab may help prolong the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor has said.
Advertisement
Ross Prentice, Ph.D., of Fred Hutchison Cancer Research Center in Seattle and colleagues analyzed data from the dietary modification trial to see if the changes in the women's diets decreased the risk of ovarian and endometrial cancer and invasive cancers overall. In the trial, nearly 20,000 women were randomly assigned to the diet modification group and almost 30,000 women ate their normal diet. The women participating in the diet were asked to reduce their fat intake to 20 percent of their overall diet, as well as eat at least five serving of fruits and vegetables a day and at least six servings of whole grains. They were followed for an average of eight years.
The risk of ovarian cancer was similar in the two groups for the first four years of follow-up, but it was reduced in the dieting group during the following four years. Women who had the highest fat intake before the trial saw the greatest reduction
![Survivors of Rare Ovarian Cancer may Retain Menstrual Function and Reproductive Ability]( "Survivors of Rare Ovarian Cancer may Retain Menstrual Function and Reproductive Ability")
A new prospective study suggests that ovarian germ cell tumour patients treated with platinum-based chemotherapy and fertility-sparing surgery may retain their menstrual function
"Ongoing ...follow-up of trial participants may provide additional valuable assessment of the effects of a low-fat dietary pattern on these and other cancer incidence rates," the authors write.
Source: Eurekalert
GAN /J
Survivors of Rare Ovarian Cancer may Retain Menstrual Function and Reproductive Ability
A new prospective study suggests that ovarian germ cell tumour patients treated with platinum-based chemotherapy and fertility-sparing surgery may retain their menstrual function
Advertisement
"Ongoing ...follow-up of trial participants may provide additional valuable assessment of the effects of a low-fat dietary pattern on these and other cancer incidence rates," the authors write.
Source: Eurekalert
GAN /J
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
Lipid nanoparticles use M13, a potent anti-ulcerative colitis compound, in an oral formulation to combat colitis-linked cancer.
Shorter radiation course is just as good as the regular one for women choosing breast reconstruction after mastectomy, saving time and money.
HAMMR's small size permits minimally invasive implantation, monitoring cancer status, and dynamically adjusting immunotherapy, akin to a glucose monitor.
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
